Heterogeneity in the use of biologics for severe asthma in Europe: a SHARP ERS study.
- DOI
- 10.1183/23120541.00273-2022
- Published
- 2022 Oct
- Container
- ERJ open research
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1183/23120541.00273-2022,
title = {Heterogeneity in the use of biologics for severe asthma in Europe: a SHARP ERS study.},
author = {Frix AN and Heaney LG and Dahlén B and Mihaltan F and Sergejeva S and Popović-Grle S and Sedlak V and Lehtimäki L and Bourdin A and Korn S and Zervas E and Csoma Z and Lúðvíksdóttir D and Butler M and Canonica GW and Grisle I and Bieksiene K and Ten Brinke A and Kuna P and Chaves Loureiro C and Nenasheva NM and Lazic Z and Škrgat S and Ramos-Barbon D and Leuppi J and Gemicioglu B and Bossios A and Porsbjerg CM and Bel EH and Djukanovic R and Louis R},
year = {2022},
journal = {ERJ open research},
doi = {10.1183/23120541.00273-2022},
url = {https://doi.org/10.1183/23120541.00273-2022}
}RIS
TY - JOUR TI - Heterogeneity in the use of biologics for severe asthma in Europe: a SHARP ERS study. AU - Frix AN AU - Heaney LG AU - Dahlén B AU - Mihaltan F AU - Sergejeva S AU - Popović-Grle S AU - Sedlak V AU - Lehtimäki L AU - Bourdin A AU - Korn S AU - Zervas E AU - Csoma Z AU - Lúðvíksdóttir D AU - Butler M AU - Canonica GW AU - Grisle I AU - Bieksiene K AU - Ten Brinke A AU - Kuna P AU - Chaves Loureiro C AU - Nenasheva NM AU - Lazic Z AU - Škrgat S AU - Ramos-Barbon D AU - Leuppi J AU - Gemicioglu B AU - Bossios A AU - Porsbjerg CM AU - Bel EH AU - Djukanovic R AU - Louis R PY - 2022 JO - ERJ open research DO - 10.1183/23120541.00273-2022 UR - https://doi.org/10.1183/23120541.00273-2022 ER -
APA
AN, F., LG, H., B, D., F, M., S, S., S, P., V, S., L, L., A, B., S, K., E, Z., Z, C., D, L., M, B., GW, C., I, G., K, B., A, T. B., P, K., C, C. L., NM, N., Z, L., S, Š., D, R., J, L., B, G., A, B., CM, P., EH, B., R, D., & R, L. (2022). Heterogeneity in the use of biologics for severe asthma in Europe: a SHARP ERS study.. ERJ open research. https://doi.org/10.1183/23120541.00273-2022
Source records
- pubmed · retrieved 2026-09-26T20:28:19.679Z